New Delhi: The prices of Serum Institute’s Covid vaccine COVISHIELD and Bharat Biotech’s COVAXIN have been slashed significantly. CEO of Serum Institute of India, SII Adar Poonawalla said in a …
Covishield, Covaxin price cut to Rs 225 per dose for private hospitals Read More
New Delhi: The Chief Executive Officer of Serum Institute of India (SII), Adar Poonawala said that, the Covid-19 deterrent vaccine for children of age more than three years will be …
Covid vaccine for children will be within next six months; Poonawala Read More
New Delhi, The Subject Expert Committee of Central Drugs Standard Control Organisation (CDSCO) met on 1st and 2nd January, 2021 and made recommendations in respect of proposal for Restricted Emergency …
Drugs Controller General of India approves emergency use of covid19 vaccine Read More
New Delhi: The Serum Institute of India (SII) will seek emergency use authorisation for the AstraZeneca Covid 19 vaccine in about two weeks. Adar Poonawalla, Founder and CEO, SII said on …
SII to seek emergency use authorisation for Covid vaccine in 2 weeks: Poonawalla Read More
New Delhi, Serum Institute of India (SII), the worlds largest vaccine manufacturer by volume, has entered into a new landmark partnership with Gavi, The Vaccine Alliance and the Bill & …
SII to produce 100M doses of Covid vax for India & LMICs Read More
